TABLE 3.
Patient no. | Age (yr) | Antibody reduction
|
||||
---|---|---|---|---|---|---|
IHAa | IRA-ELISA
|
CMA-ELISA
|
||||
Best indicator antigen | Mo of neg. resultb | Best dilution | Mo of neg. result | |||
1 | 25 | Yes | 13 | 6 | None | Anyc |
3 | 27 | Yes | 13 | 12 | 1/320 | 6 |
4 | 20 | No | 13 | 30 | 1/320 | 30 |
5 | 41 | No | 13 | 30 | 1/320 | 24 |
9 | 23 | Yes | SAPA | 54 | 1/160 | 12 |
10 | 23 | No | SAPA | 30 | 1/320 | 18 |
11 | 26 | No | 13 | 6 | None | None |
15 | 20 | Yes | SAPA, 13, 36 | 36 | 1/320 | 6 |
18 | 21 | No | 36 | 42 | 1/80 | 24 |
2 | 19 | Yes | Response only to 2 and 30 | 1/320 | 18 | |
6 | 22 | Yes | 13 | Began to descend | 1/320 | 6 |
7 | 35 | Yes | Any | Any | None | None |
8 | 22 | No | Any | Any | 1/320 | 12 |
12 | 23 | No | 36 | Began to descend | 1/80 | 18 |
13 | 21 | Yes | Any | Any | 1/320 | 30 |
14 | 29 | No | Any | Any | 1/320 | 6 |
16 | 21 | Yes | Any | Any | 1/320 | 12 |
17 | 38 | No | Any | Any | None | None |
The results indicate whether a regression of more than two titers between the pretreatment and the posttreatment evaluations occurred.
Mo of neg. result, month in which a patient became negative by any given test.
Any, positivity for all of the recombinant antigens.